Skip to content
Manufacturing
Cannabinoid Manufacturing Expertise
IntegraSyn™ Cannabinoid Manufacturing
BayMedica Cannabinoid Biosynthesis
Pharmaceutical
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Novel Cannabinoid Analogs
Cannabinoids in Development
Products
Cannabidivarin (CBDV)
Tetrahydrocannabivarin (THCV)
Cannabichromene (CBC)
Cannabicitran (CBT)
Investor
News Releases
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media
About
Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Events Calendar
Careers
Contact
Learn
What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabis Treatments for Glaucoma
Cannabinoid Science
Articles and Videos
Menu
Manufacturing
Cannabinoid Manufacturing Expertise
IntegraSyn™ Cannabinoid Manufacturing
BayMedica Cannabinoid Biosynthesis
Pharmaceutical
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Novel Cannabinoid Analogs
Cannabinoids in Development
Products
Cannabidivarin (CBDV)
Tetrahydrocannabivarin (THCV)
Cannabichromene (CBC)
Cannabicitran (CBT)
Investor
News Releases
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media
About
Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Events Calendar
Careers
Contact
Learn
What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabis Treatments for Glaucoma
Cannabinoid Science
Articles and Videos
Sign up to receive emails from InMed Pharmaceuticals
Name
*
First name
*
Last name
*
Email
*
Consent
By providing your e-mail address, you consent to receive news, press releases, quarterly and annual reports, presentations and other information from InMed Pharmaceuticals Inc. You can unsubscribe at any time.
